Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ · Healthcare
Aurinia Pharmaceuticals Inc. Net Income 2018–2025
Aurinia Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Aurinia Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was 34.4 M, a 47.17% increase year-over-year.
- Aurinia Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 110.8 M, a 1313.97% decrease year-over-year.
- Aurinia Pharmaceuticals Inc. annual net income for 2025 was 287.2 M, a 4893.08% increase from 2024.
- Aurinia Pharmaceuticals Inc. annual net income for 2024 was 5.8 M, a 107.37% decrease from 2023.
- Aurinia Pharmaceuticals Inc. annual net income for 2023 was -78.0 M, a 27.88% decrease from 2022.
- Aurinia Pharmaceuticals Inc. annual net income for 2022 was -108.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aurinia Pharmaceuticals Inc. Net Income — FAQ
Aurinia Pharmaceuticals Inc. (AUPH) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Aurinia Pharmaceuticals Inc.'s net income?
Aurinia Pharmaceuticals Inc. (AUPH) reported net income of $287M for fiscal 2025.
Where can I see AUPH's net income history?
The chart and table above show Aurinia Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.